²»Í¬ÓªÑø·çÏÕɸ²é·½·¨¶ÔÒÈÊ®¶þÖ¸³¦Çгý»¼ÕßÊÊÓÃÐԵĶԱÈ
ÓªÑø×´¿ö,ÈËÌå,1²ÄÁÏÓë·½·¨,1Ñо¿¶ÔÏó,2ÄÉÅűê×¼,3¹Û²ìÖ¸±ê,4ͳ¼ÆÑ§´¦Àí,2½á¹û,1»¼Õß»ù±¾×ÊÁÏ,2NRS2002ÓëPG-SGAµÄÒ»ÖÂÐÔ¼ìÑé,3NRS2002,PG-SGAÓªÑøÆÀ¹À½á¹û¶Ô±È,4NRS2
ÍõÀèÄÈ£¬±åÏþ½à£¬³Â´óÓ³ðع¶«£¬¸ðÎÀºì*(.ÄϾ©´óѧҽѧԺ¸½Êô¹Ä¥ҽԺҩѧ²¿£¬ÄϾ©20008£»2.ÉòÑôÒ©¿Æ´óѧÉúÃü¿ÆÑ§ÓëÉúÎïÖÆÒ©Ñ§Ôº£¬ÉòÑô 006£».ÄϾ©´óѧҽѧԺ¸½Êô¹ÄÂ¥Ò½Ôº¸Îµ¨ÒÈÍâ¿Æ£¬ÄϾ© 20008)Ŀǰ£¬ÒÈÊ®¶þÖ¸³¦ÇгýÊõ(pancreaticoduodenectomy£¬PD)ÊÇÖÎÁƵ¨¹ÜÏ¶ΰ©¡¢ÒÈÍ·°©¡¢Ê®¶þÖ¸³¦°©µÈµÄÊ×Ñ¡ÊÖÊõ·½Ê½¡£PD ÇгýÆ÷¹Ù¡¢×éÖ¯¶à£¬ÁܰÍÇåɨ·¶Î§´ó£¬Ïû»¯µÀÖØ½¨¸´ÔÓ£¬ÊǸ¹²¿Íâ¿ÆÊÖÊõÖÐÄѶȽϴ󡢴´É˽ϴóµÄÊÖÊõÖ®Ò»¡£½üÄêÀ´£¬Ëæ×ÅÊÖÊõ¼¼ÊõµÄ¸Ä½øºÍÒ½ÁÆË®Æ½µÄ½ø²½£¬PD ÊõºóËÀÍöÂÊϽµµ½Ô¼5%[1]£¬µ«Êõºó²¢·¢Ö¢·¢ÉúÂÊÈԸߴï40%¡«50%[2]£¬ÒÈðü¡¢Î¸ÅÅ¿ÕÑÓ³Ù¡¢¸ÐȾµÈ³£¼ûÊõºó²¢·¢Ö¢£¬ÒÔ¼°ÊÖÊõ´´ÉËÓëÊõºóµÄÓ¦¼¤·´Ó¦¾ù»áÓ°Ï컼ÕßµÄÓªÑø×´¿ö¡£Ä¿Ç°£¬ÆÕͨÍâ¿Æ½ÓÊÜ賦ÊÖÊõ»¼ÕßÖÐÓÐ48%¡«77%´æÔÚÓªÑø²»Á¼[3]£¬ÑÏÖØÓ°ÏìÍâ¿Æ»¼ÕßÁÙ´²½á¾Ö¡£Kanda µÈ[4]±¨µÀÊõÇ°ÓªÑø×´¿öÓëPD Êõºó»¼ÕßÁÙ´²½á¾ÖµÄ¹ØÁª£¬²¢µÃ³öÓªÑøÈ±·¦Ö¸±ê¿ÉÒÔ°ïÖúÁÙ´²Ò½Ê¦¶Ô»¼Õß½øÐлý¼«µÄÓªÑøÖ§³ÖÖÎÁÆ¡£ÓªÑøÆÀ¹ÀµÄÄ¿µÄÊÇÈ·¶¨»¼ÕßÏÖÓлòDZÔÚµÄÓªÑø²»Á¼£¬ÒԱ㼰ʱºÏÀíµØÌá¹©ÓªÑøÖ§³Ö£¬¸ÄÉÆ»¼ÕßÓªÑø×´¿ö¼°ÁÙ´²½á¾Ö[5]¡£ÓÐÏà¹ØÑо¿Ö¸³öÊõÇ°ÓªÑøÆÀ¹ÀÎªÓªÑø²»Á¼»ò¾ßÓÐÓªÑø·çÏյϼÕß½øÐÐÊõÇ°ÓªÑøÖ§³ÖÖÎÁƺ󣬿ɸÄÉÆ»¼ÕßÊõÇ°ÓªÑø×´¿ö£¬Ô¤ºóÁ¼ºÃ[6]¡£ÓÉÓÚÓªÑø²»Á¼Ó뻼ÕßÔ¤ºóÃÜÇÐÏà¹Ø£¬¶ÔÐÐPD »¼ÕßÊµÊ©ÓªÑøÖ§³Ö¸ÄÉÆ»¼ÕßÊõÇ°ÓªÑø×´¿öÐèÏÈÆÀ¹ÀÁ˽⻼ÕßµÄÓªÑø×´¿ö¡£ÁÙ´²Éϳ£ÓõÄÓªÑøÉ¸²é¼°ÆÀ¶¨µÄ¹¤¾ß½Ï¶à£¬²»Í¬ÓªÑøÉ¸²é¹¤¾ßÊÊÓ÷¶Î§¼°ÓÅȱµã¸÷²»Ïàͬ£¬ÐèÑ¡ÔñºÏÊʵÄÓªÑø·çÏÕɸ²é¹¤¾ß¡£
Ŀǰ£¬ÁÙ´²Éϳ£ÓõÄÊõÇ°ÓªÑøÉ¸²éÁ¿±í½Ï¶à£¬ÆäÖÐÓªÑø·çÏÕɸ²é2002(Nutritional Risk Screening 2002£¬NRS 2002)¡¢»¼ÕßÖ÷¹ÛÕûÌåÆÀ¹À(patient-generated subjective global assessment£¬PG-SGA)ÔÚÁÙ´²Ó¦Óý϶ࡣÖлªÒ½Ñ§»á³¦Í⳦ÄÚÓªÑøÑ§·Ö»á(CSPEN)¡¢Å·ÖÞ³¦Í⳦ÄÚÓªÑøÑ§»á(ESPEN)µÈÖ¸Äϼ°×¨¼Ò¹²Ê¶¾ùÍÆ¼öNRS 2002½øÐÐÊõÇ°ÓªÑø·çÏÕɸ²é[7-9]¡£NRS 2002 ɸ²éÊÊÓÃÓÚ¸÷Àà18 ¡«90 ËêµÄסԺ»¼Õß[10]¡£PG-SGA ÆÀ¹ÀÊÇÔÚÖ÷¹ÛÕûÌåÆÀ¹À(subjective global assessment£¬SGA)µÄ»ù´¡ÉÏÔö¼ÓÁËÌå¸ñ¼ì²éµÈÆÀ·ÖÏPGSGA ÆÀ¹À½ÏSGA ¸ü¼ÓϸÖ¡¢ÑϽ÷£¬¸üÄÜÈ«Ãæ·´Ó³»¼ÕßµÄÓªÑø×´¿ö£¬¸üÊÊÓÃÓÚÖ×Áö»¼ÕßÓªÑøÆÀ¹À[11]¡£Ö»ÓÐÊõÇ°ÓªÑøÉ¸²é»òÆÀ¹À¶¼²»ÄÜÈ«Ãæ·´Ó³»¼ÕßÊõÇ°ÓªÑø×´¿ö¡£Òò´Ë£¬±¾Ñо¿²ÉÓÃNRS 2002¡¢PG-SGA ¶ÔÐÐPD »¼Õß½øÐÐÊõÇ°ÓªÑø·çÏÕɸ²éÓëÆÀ¹À ......
ÄúÏÖÔڲ鿴ÊÇÕªÒªÒ³£¬È«Îij¤ 11334 ×Ö·û¡£